Related Experiment Video
Updated: May 20, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Pharmaceutical Industry 5.0: The Role of Drug Discovery Technology, Innovation, and Digital Transformation in
Virendra S Gomase1,2,3, Rupali Sharma2, Suchita P Dhamane3
1S.P. Mandali's, Prin. L. N. Welingkar Institute of Management Development & Research (PGDM), Mumbai, 400019, India.
Introduction:
The pharmaceutical industry is undergoing a profound transformation driven by digitalization, innovation, and cutting-edge emerging technologies. The concept of Pharmaceutical Industry 5.0 has emerged as the sector adjusts to a rapidly shifting global environment, with cutting-edge technologies like artificial intelligence (AI), blockchain, automation, and personalized medicine playing a crucial role in determining the future. This new phase integrates advanced technologies such as artificial intelligence (AI), blockchain, automation, and personalized medicine, which are shaping the future of drug discovery, manufacturing, and distribution. The objective of this study is to explore how the transition to Industry 5.0 is enhancing the pharmaceutical industry's resilience, innovation, and sustainability in the face of global crises such as pandemics, regulatory changes, and market disruptions.
Method:
This research study investigates the integration of emerging technologies in pharmaceutical processes and analyzes their impact on operational efficiency, supply chain optimization, personalized medicine, and global access to treatment. The concept of economic resiliency is used as a central framework to evaluate the industry's adaptive capacity.
Discussion:
Emerging technologies are enabling faster and more efficient research and development (R&D), paving the way for personalized and targeted therapies. Pharmaceutical companies are leveraging innovation to explore new business models focused on sustainability, predictive analytics, and big data. Additionally, digital transformation is reshaping healthcare delivery through telemedicine, AI diagnostics, and remote monitoring, thereby expanding global access to medical treatments.
Conclusion:
The adoption of Industry 5.0 principles allows pharmaceutical companies to strengthen economic resilience, drive innovation, and achieve sustainable growth. By embracing digital tools and fostering collaboration, the industry can enhance patient outcomes and maintain long-term viability in an increasingly complex and uncertain global economy.
Related Concept Videos
Drug Discovery: Overview
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Biopharmaceutics and Pharmacokinetics: Overview
Drug Control Governance: Regulatory Bodies and Their Impact